REM睡眠失张力缺失区分认知障碍老年人的突触核蛋白病
研究纳入61名接受多导睡眠监测的老年人,其中46例认知障碍(20例可能突触核蛋白病,26例可能非突触核蛋白病),15名匹配对照。定量分析颏下肌和胫前肌的REM睡眠期失张力缺失(RSWA)指标,发现颏下肌RSWA在突触核蛋白病中更高,多个阈值可高特异性区分,且不依赖梦境演绎行为。
要点
- 颏下肌RSWA在可能突触核蛋白病中高于非突触核蛋白病,胫前肌无差异。
- 颏下肌紧张性5.6%、任何性15.0%、时相性10.8%阈值区分突触核蛋白病特异性高。
- 无梦境演绎行为者颏下肌RSWA仍更高,定量法比定性法更常检出RSWA。
核心结论
- 颏下肌RSWA升高可区分认知障碍老年人的可能突触核蛋白病与可能非突触核蛋白病,即使无梦境演绎症状。
- 定量RSWA分析有助于认知障碍表型鉴别,但需病理确诊研究进一步验证。
研究设计与样本
- 研究纳入61名接受多导睡眠监测的老年人:46例认知障碍(20例可能突触核蛋白病,26例可能非突触核蛋白病,包括15例可能阿尔茨海默病和11例额颞叶痴呆)及15名年龄性别匹配对照。
- 定量计算颏下肌和胫前肌RSWA指标及自动REM失张力指数,进行组间比较和回归,用ROC曲线确定诊断阈值。
主要发现
- 颏下肌RSWA在突触核蛋白病中高于非突触核蛋白病,胫前肌RSWA无差异。
- 颏下肌紧张性5.6%(AUC 0.791)、任何性15.0%(AUC 0.871)、时相性10.8%(AUC 0.863)及胫前肌时相性31.4%(AUC 0.694)阈值可区分突触核蛋白病。
- 无梦境演绎行为的亚组中,突触核蛋白病患者颏下肌RSWA仍高于非突触核蛋白病。
- 定量法检测RSWA的频率高于定性法(p = 0.0001)。
关键数值与推荐
- 颏下肌紧张性RSWA阈值5.6%(AUC 0.791)区分突触核蛋白病。
- 颏下肌任何性RSWA阈值15.0%(AUC 0.871)区分突触核蛋白病。
- 颏下肌时相性RSWA阈值10.8%(AUC 0.863)区分突触核蛋白病。
- 胫前肌时相性RSWA阈值31.4%(AUC 0.694)区分突触核蛋白病。
临床怎么用
- 对认知障碍老年人,定量颏下肌RSWA可辅助鉴别可能突触核蛋白病与可能非突触核蛋白病。
- 即使无梦境演绎症状,也应关注颏下肌RSWA升高,提示潜在突触核蛋白病。
- 定量RSWA分析比定性法更敏感,建议在认知障碍评估中纳入多导睡眠监测定量指标。
局限性
- 研究为Class III证据,诊断基于临床表型而非病理确诊,需病理确认研究验证RSWA的诊断效用。
- 样本量有限,结论需更大样本重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether quantitative polysomnographic REM sleep without atonia (RSWA) distinguishes between cognitive impairment phenotypes. BACKGROUND: Neurodegenerative cognitive impairment in older adults predominantly correlates with tauopathy or synucleinopathy. Accurate antemortem phenotypic diagnosis has important prognostic and treatment implications; additional clinical tools might distinguish between dementia syndromes. METHODS: We quantitatively analyzed RSWA in 61 older adults who underwent polysomnography including 46 with cognitive impairment (20 probable synucleinopathy), 26 probable non-synucleinopathy (15 probable Alzheimer disease, 11 frontotemporal lobar dementia), and 15 age- and sex-matched controls. Submentalis and anterior tibialis RSWA metrics and automated REM atonia index were calculated. Group statistical comparisons and regression were performed, and receiver operating characteristic curves determined diagnostic RSWA thresholds that best distinguished synucleinopathy phenotype. RESULTS: Submentalis-but not anterior tibialis RSWA-was greater in synucleinopathy than nonsynucleinopathy; several RSWA diagnostic thresholds distinguished synucleinopathy with excellent specificity including submentalis tonic, 5.6% (area under the curve [AUC] 0.791); submentalis any, 15.0% (AUC 0.871); submentalis phasic, 10.8% (AUC 0.863); and anterior tibialis phasic, 31.4% (AUC 0.694). In the subset of patients without dream enactment behaviors, submentalis RSWA was also greater in patients with synucleinopathy than in those without synucleinopathy. RSWA was detected more frequently by quantitative than qualitative methods (p = 0.0001). CONCLUSION: Elevated submentalis RSWA distinguishes probable synucleinopathy from probable nonsynucleinopathy in cognitively impaired older adults, even in the absence of clinical dream enactment symptoms. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that quantitative RSWA analysis is useful for distinguishing cognitive impairment phenotypes. Further studies with pathologic confirmation of dementia diagnoses are needed to confirm the diagnostic utility of RSWA in dementia.
引用
- McCarter SJ, Tabatabai GM, Jong HY, et al. REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment. Neurology. 2019. PMID: 31831602. doi:10.1212/WNL.0000000000008694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。